Whereas VEGF levels within the tumour environment appear to directly correlate with the overall microvessel density, specific inhibition or trapping of VEGF produced by cancer cells results in a significant reduction of tumour angiogenesis, concomitant with reduced tumour growth and, consequently, the inhibition of metastasis. The gene discussed is VEGFA; the disease is cancer.